DMPI Quote, Trading Chart, DelMar Pharmaceuticals Inc.
home / stock / dmpi / dmpi quote
$1.34 Last:
7.2% Change Percent:
$1.22 Open:
$1.34 Previous Close:
$1.35 High:
$1.17 Low:
1,321,048 Volume:
08/19/2020 04:58:56 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
DMPI Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2020-08-19 | 1.22 | 1.34 | 1.35 | 1.17 | 1,321,048 |
| 2020-08-18 | 1.16 | 1.25 | 1.285 | 1.16 | 1,067,795 |
| 2020-08-17 | 1.28 | 1.16 | 1.31 | 1.0933 | 2,871,179 |
| 2020-08-14 | 1.18 | 1.16 | 1.3 | 1.145 | 1,073,786 |
| 2020-08-13 | 1.15 | 1.16 | 1.22 | 1.07 | 781,756 |
| 2020-08-12 | 1.29 | 1.24 | 1.34 | 1.12 | 1,475,278 |
| 2020-08-11 | 1.23 | 1.26 | 1.53 | 1.2 | 6,705,884 |
| 2020-08-10 | 1.11 | 1.18 | 1.19 | 1.1 | 911,630 |
| 2020-08-07 | 1.05 | 1.06 | 1.06 | 0.993 | 256,857 |
| 2020-08-06 | 1.05 | 1.03 | 1.07 | 1 | 403,405 |
| 2020-08-05 | 0.93 | 1.04 | 1.05 | 0.93 | 524,270 |
| 2020-08-04 | 0.94 | 0.95 | 0.95 | 0.9001 | 143,630 |
| 2020-08-03 | 0.92 | 0.9418 | 0.981 | 0.861 | 367,576 |
| 2020-07-31 | 1.02 | 0.9537 | 1.0301 | 0.93 | 540,426 |
| 2020-07-30 | 1.02 | 1.03 | 1.06 | 1 | 505,073 |
| 2020-07-29 | 1.03 | 1.06 | 1.15 | 0.982 | 1,592,731 |
| 2020-07-28 | 1.01 | 1.05 | 1.09 | 0.93 | 1,179,088 |
| 2020-07-27 | 0.94 | 1.04 | 1.07 | 0.8522 | 2,101,250 |
| 2020-07-24 | 0.95 | 1.005 | 1.05 | 0.95 | 1,118,526 |
| 2020-07-23 | 1.24 | 1.12 | 1.26 | 1.08 | 1,378,679 |
DelMar Pharmaceuticals Inc. Company Name:
DMPI Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
SAN DIEGO , Aug. 18, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that it has entered into definitive agreements with investors providing for the sale and issuance of up to 19,587 shares of its Series C Convert...
-
SAN DIEGO , Aug. 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that all proposals related to the proposed merger between DelMar and Adgero were approved by DelMar's stockholders at a special meeting held on August 14...
-
SAN DIEGO , July 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today that it will be conducting a conference call to discuss...